# Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

> **NCT00002791** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group**

## Conditions studied

- Sarcoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** dacarbazine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** ifosfamide
- **DRUG:** mesna
- **PROCEDURE:** conventional surgery
- **RADIATION:** brachytherapy
- **RADIATION:** intraoperative radiation therapy
- **RADIATION:** radioisotope therapy

## Key facts

- **NCT ID:** NCT00002791
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 2002-05
- **Final completion:** 2013-11
- **Target enrollment:** — (—)
- **Last updated:** 2014-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002791, "Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*